News

The clearance allows BacTx test use on leukocyte-reduced whole blood-derived platelet units, a type of platelet preparation which shows bacterial contamination. In the studies reported to the FDA,

Galeterone disrupts androgen receptor (AR) signaling, the key driver of CRPC, through a novel triple mechanism of action. The oral drug selectively inhibits CYP17 lyase to prevent testosterone

The new member of the group will be producing starting materials, intermediates and other fine chemical products for pharma and non-pharma applications in industrial quantities. The new 55,000m2

The company plans to begin a Phase II proof of concept study of AVP-923 during the third calendar quarter of 2012. Avanir Pharmaceuticals R&D senior vice president Joao

The company has also unveiled Openvas Co, a combination preparation for use with a diuretic. Openvas and Openvas Co are the first pharmaceuticals marketed by a Daiichi Sankyo

The alliance will be focused on going together with Cubist’s drug discovery programs with new lead compounds in the development of new anti-bacterial drugs. Fundacion MEDINA scientific director

Further details on the partnership were kept confidential. Avid Bioservices president Steven King said, "We are pleased to be working with Phage to offer their proprietary expression system,

The collaboration aims at offering joint services for the expression of recombinant proteins with site-specific modification and labeling, such as PEGylation for half-life extension of proteins. Almac developed

The study of 3,883 patients, with secondary hyperparathyroidism (HPT) and chronic kidney disease (CKD) receiving dialysis, evaluated Sensipar/Mimpara (cinacalcet) for the reduction of the risk of mortality and